Published in Am J Obstet Gynecol on March 01, 2008
Developmental programming and hypertension. Curr Opin Nephrol Hypertens (2009) 1.17
Maternal low-protein diet or hypercholesterolemia reduces circulating essential amino acids and leads to intrauterine growth restriction. Diabetes (2008) 1.00
Influence of maternal dysmetabolic conditions during pregnancy on cardiovascular disease. J Cardiovasc Transl Res (2009) 0.90
Fetoplacental vascular endothelial dysfunction as an early phenomenon in the programming of human adult diseases in subjects born from gestational diabetes mellitus or obesity in pregnancy. Exp Diabetes Res (2011) 0.86
Changes in serum lipid levels during pregnancy in type 1 and type 2 diabetic subjects. Diabetes Care (2010) 0.84
Circulating TRAIL shows a significant post-partum decline associated to stressful conditions. PLoS One (2011) 0.76
Can physiologic hyperlipidemia during pregnancy be the culprit for atherogenesis in utero? Am J Obstet Gynecol (2008) 0.75
Maternal C-reactive protein and atherosclerosis. Am J Obstet Gynecol (2009) 0.75
Adenovirus serotype 5 hexon mediates liver gene transfer. Cell (2008) 5.00
Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med (2003) 4.47
Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma. J Clin Invest (2004) 3.23
Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc Natl Acad Sci U S A (2002) 3.18
IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. J Clin Invest (2004) 2.56
Endothelial progenitor cells restore renal function in chronic experimental renovascular disease. Circulation (2009) 2.24
Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer. Clin Cancer Res (2002) 2.01
Distinct renal injury in early atherosclerosis and renovascular disease. Circulation (2002) 2.01
Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis. Arterioscler Thromb Vasc Biol (2003) 1.91
MMP inhibition and the development of cerebrovascular atherosclerosis: The road ahead. Stroke (2002) 1.76
Antioxidant intervention blunts renal injury in experimental renovascular disease. J Am Soc Nephrol (2004) 1.70
Simvastatin promotes angiogenesis and prevents microvascular remodeling in chronic renal ischemia. FASEB J (2006) 1.69
Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. Circ Res (2002) 1.69
Reduced in vivo aortic uptake of radiolabeled oxidation-specific antibodies reflects changes in plaque composition consistent with plaque stabilization. Arterioscler Thromb Vasc Biol (2004) 1.68
Nutrition, physical activity, and cardiovascular disease: an update. Cardiovasc Res (2006) 1.68
Mediator complexes and eukaryotic transcription regulation: an overview. Biochimie (2007) 1.60
Maternal hypercholesterolemia during pregnancy promotes early atherogenesis in LDL receptor-deficient mice and alters aortic gene expression determined by microarray. Circulation (2002) 1.58
Simvastatin preserves the structure of coronary adventitial vasa vasorum in experimental hypercholesterolemia independent of lipid lowering. Circulation (2002) 1.57
Therapeutic targeting of the stem cell niche in experimental hindlimb ischemia. Nat Clin Pract Cardiovasc Med (2008) 1.47
Antioxidant intervention attenuates myocardial neovascularization in hypercholesterolemia. Circulation (2004) 1.46
Simvastatin prevents coronary microvascular remodeling in renovascular hypertensive pigs. J Am Soc Nephrol (2007) 1.38
Brain protection using autologous bone marrow cell, metalloproteinase inhibitors, and metabolic treatment in cerebral ischemia. Proc Natl Acad Sci U S A (2007) 1.35
A diet-induced hypercholesterolemic murine model to study atherogenesis without obesity and metabolic syndrome. Arterioscler Thromb Vasc Biol (2007) 1.31
Angiogenesis in atherogenesis. Arterioscler Thromb Vasc Biol (2006) 1.28
The role of oxidative stress in adult critical care. Free Radic Biol Med (2005) 1.26
Animal models of hypertension: an overview. J Lab Clin Med (2005) 1.26
Pomegranate juice protects nitric oxide against oxidative destruction and enhances the biological actions of nitric oxide. Nitric Oxide (2006) 1.23
CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy. Proc Natl Acad Sci U S A (2010) 1.21
Antioxidant intervention prevents renal neovascularization in hypercholesterolemic pigs. J Am Soc Nephrol (2004) 1.19
Role of oxidative stress in remodeling of the myocardial microcirculation in hypertension. Arterioscler Thromb Vasc Biol (2006) 1.16
Beneficial effects of antioxidants and L-arginine on oxidation-sensitive gene expression and endothelial NO synthase activity at sites of disturbed shear stress. Proc Natl Acad Sci U S A (2003) 1.16
Massive-scale RNA-Seq analysis of non ribosomal transcriptome in human trisomy 21. PLoS One (2011) 1.15
Minimally oxidized LDL offsets the apoptotic effects of extensively oxidized LDL and free cholesterol in macrophages. Arterioscler Thromb Vasc Biol (2006) 1.14
Scavenger receptors target glycolipids for natural killer T cell activation. J Clin Invest (2012) 1.13
Mechanisms by which exercise training benefits patients with heart failure. Nat Rev Cardiol (2009) 1.11
Oxidation-sensitive mechanisms, vascular apoptosis and atherosclerosis. Trends Mol Med (2003) 1.10
Finding new HLA-C alleles is useful for the success of bone marrow transplantation. Saudi J Kidney Dis Transpl (2013) 1.09
Beneficial effects of pomegranate juice on oxidation-sensitive genes and endothelial nitric oxide synthase activity at sites of perturbed shear stress. Proc Natl Acad Sci U S A (2005) 1.07
Expression of transcription factor Yin Yang 1 in human osteosarcomas. Eur J Cancer (2006) 1.06
External iliac artery pseudoaneurysm complicating renal transplantation. Interact Cardiovasc Thorac Surg (2009) 1.06
Comment about the article by Bisson-Vaivre et al.: "The role of HLA and KIR in anti-TNF therapy". Joint Bone Spine (2012) 1.06
Role of oxidative stress in experimental sepsis and multisystem organ dysfunction. Free Radic Res (2006) 1.06
Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis. Curr Atheroscler Rep (2004) 1.05
Peroxisome proliferator-activated receptors: how their effects on macrophages can lead to the development of a new drug therapy against atherosclerosis. Annu Rev Pharmacol Toxicol (2006) 1.05
High glucose downregulates endothelial progenitor cell number via SIRT1. Biochim Biophys Acta (2008) 1.05
Novel toll-like receptor 9 agonist induces epidermal growth factor receptor (EGFR) inhibition and synergistic antitumor activity with EGFR inhibitors. Clin Cancer Res (2006) 1.05
The influence of pomegranate fruit extract in comparison to regular pomegranate juice and seed oil on nitric oxide and arterial function in obese Zucker rats. Nitric Oxide (2007) 1.04
The beneficial effects of antioxidant supplementation in enteral feeding in critically ill patients: a prospective, randomized, double-blind, placebo-controlled trial. Anesth Analg (2004) 1.04
Deletion of Yin Yang 1 protein in osteosarcoma cells on cell invasion and CXCR4/angiogenesis and metastasis. Cancer Res (2008) 1.04
Chronic treatment with nitric oxide-releasing aspirin reduces plasma low-density lipoprotein oxidation and oxidative stress, arterial oxidation-specific epitopes, and atherogenesis in hypercholesterolemic mice. Proc Natl Acad Sci U S A (2002) 1.04
Intracytoplasmic injection of morphologically selected spermatozoa (IMSI) improves outcome after assisted reproduction by deselecting physiologically poor quality spermatozoa. J Assist Reprod Genet (2010) 1.02
Maternal immunization programs postnatal immune responses and reduces atherosclerosis in offspring. Circ Res (2006) 1.02
c-Myc oncoprotein: cell cycle-related events and new therapeutic challenges in cancer and cardiovascular diseases. Cell Cycle (2003) 1.00
Impairment of circulating endothelial progenitors in Down syndrome. BMC Med Genomics (2010) 0.99
Cardioprotective effect of ischemic preconditioning is preserved in food-restricted senescent rats. Am J Physiol Heart Circ Physiol (2002) 0.99
Hypercholesterolemia and hypertension have synergistic deleterious effects on coronary endothelial function. Arterioscler Thromb Vasc Biol (2003) 0.98
Onset of experimental severe cardiac fibrosis is mediated by overexpression of Angiotensin-converting enzyme 2. Hypertension (2009) 0.97
The effect of angiotensin-converting enzyme inhibition on endothelial function and oxidant stress. Eur J Pharmacol (2003) 0.97
Effects of intracellular acidosis on endothelial function: an overview. J Crit Care (2011) 0.97
p66Shc deletion confers vascular protection in advanced atherosclerosis in hypercholesterolemic apolipoprotein E knockout mice. Endothelium (2008) 0.96
Six-minute walking test but not ejection fraction predicts mortality in elderly patients undergoing cardiac rehabilitation following coronary artery bypass grafting. Eur J Prev Cardiol (2011) 0.96
Endothelin-1 receptor blockade prevents renal injury in experimental hypercholesterolemia. Kidney Int (2003) 0.96
Effects of a pomegranate fruit extract rich in punicalagin on oxidation-sensitive genes and eNOS activity at sites of perturbed shear stress and atherogenesis. Cardiovasc Res (2006) 0.96
Hypertension exacerbates the effect of hypercholesterolemia on the myocardial microvasculature. Cardiovasc Res (2003) 0.96
Identification of valid reference housekeeping genes for gene expression analysis in tumor neovascularization studies. Clin Transl Oncol (2012) 0.95
Developmental programming: maternal hypercholesterolemia and immunity influence susceptibility to atherosclerosis. Nutr Rev (2007) 0.95
Redox-sensitive myocardial remodeling and dysfunction in swine diet-induced experimental hypercholesterolemia. Atherosclerosis (2006) 0.95
Understanding the immunoangiostatic CXC chemokine network. Cardiovasc Res (2008) 0.94
Chronic antioxidant supplementation attenuates nuclear factor-kappa B activation and preserves endothelial function in hypercholesterolemic pigs. Cardiovasc Res (2002) 0.94
Targeting c-Myc, Ras and IGF cascade to treat cancer and vascular disorders. Cell Cycle (2006) 0.94
Efficacy and age-related effects of nitric oxide-releasing aspirin on experimental restenosis. Proc Natl Acad Sci U S A (2002) 0.93
Effects of ACE inhibition on circulating endothelial progenitor cells, vascular damage, and oxidative stress in hypertensive patients. Eur J Clin Pharmacol (2011) 0.93
Disparate effects of simvastatin on angiogenesis during hypoxia and inflammation. Life Sci (2008) 0.92
Chronic antioxidant supplementation impairs coronary endothelial function and myocardial perfusion in normal pigs. Hypertension (2006) 0.92
Novel challenges in exploring peptide ligands and corresponding tissue-specific endothelial receptors. Eur J Cancer (2007) 0.91
Unraveling pleiotropic effects of statins on plaque rupture. Arterioscler Thromb Vasc Biol (2002) 0.91
Physical training and metabolic supplementation reduce spontaneous atherosclerotic plaque rupture and prolong survival in hypercholesterolemic mice. Proc Natl Acad Sci U S A (2006) 0.91
Detrimental effects of Bartonella henselae are counteracted by L-arginine and nitric oxide in human endothelial progenitor cells. Proc Natl Acad Sci U S A (2008) 0.90
Oxidative stress-related increase in ubiquitination in early coronary atherogenesis. FASEB J (2003) 0.90
Effect of low doses of red wine and pure resveratrol on circulating endothelial progenitor cells. J Biochem (2007) 0.90
Influence of maternal dysmetabolic conditions during pregnancy on cardiovascular disease. J Cardiovasc Transl Res (2009) 0.90
Therapeutic effects of autologous bone marrow cells and metabolic intervention in the ischemic hindlimb of spontaneously hypertensive rats involve reduced cell senescence and CXCR4/Akt/eNOS pathways. J Cardiovasc Pharmacol (2007) 0.90
CXCR4 inhibitors: tumor vasculature and therapeutic challenges. Recent Pat Anticancer Drug Discov (2012) 0.89
Functional impairment of hematopoietic progenitor cells in patients with coronary heart disease. Eur J Haematol (2007) 0.89
Evidence of key role of Cdk2 overexpression in pemphigus vulgaris. J Biol Chem (2008) 0.89
Antioxidants increase number of progenitor endothelial cells through multiple gene expression pathways. Free Radic Res (2008) 0.89
Antioxidant vitamins induce angiogenesis in the normal pig kidney. Am J Physiol Renal Physiol (2007) 0.89
Impaired fetal growth, cardiovascular disease, and the need to move on. Circulation (2008) 0.89
Autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the diabetic mouse hindlimb. Cell Cycle (2006) 0.89